About Piramal Pharma II Private Limited
Data last updated:
Piramal Pharma II Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 June 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2022PTC384232.
The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹34.01 Cr. It is led by directors Amit Anant Bapat (Whole-Time Director) and Surinder Bhawanidas Gulati.
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gr. Flr Ananta Building Agastya Corp. Park Kamani Junction Lbs Marg Kurla W, Mumbai, Maharashtra, India – 400070.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website piramal.com.
Company details
Contact details
Piramal Pharma II Private Limited's registered office is in Mumbai, Maharashtra.
- Social Media
- Registered AddressGr. Flr Ananta Building Agastya Corp. Park Kamani Junction Lbs Marg Kurla W, Mumbai, Maharashtra, India – 400070
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Piramal Pharma II Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Piramal Pharma II Private Limited, buy the company report.
Board of directors of Piramal Pharma II Private Limited
Piramal Pharma II has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surinder Bhawanidas Gulati | Director | 08 Jun 2022 | 4 Years 4 Months | Current |
| Amit Anant Bapat | Whole-Time Director | 08 Jun 2022 | 4 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Piramal Pharma II Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Piramal Pharma II Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Piramal Pharma II Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Piramal Pharma II Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Amit Anant Bapat ceased to be Director on 19 Apr 2023.
News
Frequently asked questions
Piramal Pharma II is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 June 2022 (4+ years old) and is registered under CIN U24230MH2022PTC384232.
Piramal Pharma II has 2 current directors:
- Amit Anant Bapat - Whole-Time Director
- Surinder Bhawanidas Gulati - Director
The latest financial statements of Piramal Pharma II on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Piramal Pharma II is U24230MH2022PTC384232. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Piramal Pharma II was incorporated on 08 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Amit Anant Bapat ceased to be Director on 19 Apr 2023. Amit Anant Bapat was appointed as Whole-Time Director on 08 Jun 2022. Surinder Bhawanidas Gulati was appointed as Director on 08 Jun 2022.
Piramal Pharma II can be reached through the website piramal.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Piramal Pharma II is at Gr. Flr Ananta Building Agastya Corp. Park Kamani Junction Lbs Marg Kurla W, Mumbai, Maharashtra, India – 400070.
Piramal Pharma II operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Piramal Pharma II is compliant as of 19 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
